TY - JOUR
T1 - Quantifying cardiometabolic risk using modifiable non-self-reported risk factors
AU - Marino, Miguel
AU - Li, Yi
AU - Pencina, Michael J.
AU - D'Agostino, Ralph B.
AU - Berkman, Lisa F.
AU - Buxton, Orfeu M.
N1 - Funding Information:
This study was supported by the Robert Wood Johnson Foundation Health and Society Scholars program at Harvard (Grant 69248 ), the Institute on Aging (Grant U01AG027669 ), and the Work, Family, and Health Network ( WorkFamilyHealthNetwork.org ), which is funded by a cooperative agreement through the NIH and CDC: Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grants U01HD051217 , U01HD051218 , U01HD051256 , and U01HD051276 ); National Institute on Aging (Grant U01AG027669 ); Office of Behavioral and Science Sciences Research, National Heart, Lung, and Blood Institute ( R01HL107240 ); and National Institute for Occupational Safety and Health (Grants U01OH008788 and U01HD059773 ). Orfeu M. Buxton received an investigator-initiated grant from Sepracor Inc. (now Sunovion; ESRC-0977, ClinicalTrials.gov Identifier NCT00900159). Grants from the William T. Grant Foundation, Alfred P. Sloan Foundation, and the Administration for Children and Families provided additional funding. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of these institutes and offices. Ralph B. D’Agostino was supported by Framingham study contract NHLBI N01-HC-25195. Michael J. Pencia received support from the Framingham Heart Study. We thank the National Heart, Lung, and Blood Institute for providing Framingham data and are grateful to Framingham participants and staff.
PY - 2014/8
Y1 - 2014/8
N2 - Background Sensitive general cardiometabolic risk assessment tools of modifiable risk factors would be helpful and practical in a range of primary prevention interventions or for preventive health maintenance. Purpose To develop and validate a cumulative general cardiometabolic risk score that focuses on non-self-reported modifiable risk factors such as glycosylated hemoglobin (HbA1c) and BMI so as to be sensitive to small changes across a span of major modifiable risk factors, which may not individually cross clinical cut-off points for risk categories. Methods We prospectively followed 2,359 cardiovascular disease (CVD)-free subjects from the Framingham offspring cohort over a 14-year follow-up. Baseline (fifth offspring examination cycle) included HbA1c and cholesterol measurements. Gender-specific Cox proportional hazards models were considered to evaluate the effects of non-self-reported modifiable risk factors (blood pressure, total cholesterol, high-density lipoprotein cholesterol, smoking, BMI, and HbA1c) on general CVD risk. We constructed 10-year general cardiometabolic risk score functions and evaluated its predictive performance in 2012-2013. Results HbA1c was significantly related to general CVD risk. The proposed cardiometabolic general CVD risk model showed good predictive performance as determined by cross-validated discrimination (male C-index=0.703, 95% CI=0.668, 0.734; female C-index=0.762, 95% CI=0.726, 0.801) and calibration (lack-of-fit chi-square=9.05 [p=0.338] and 12.54 [p=0.128] for men and women, respectively). Conclusions This study presents a risk factor algorithm that provides a convenient and informative way to quantify cardiometabolic risk on the basis of modifiable risk factors that can motivate an individual's commitment to prevention and intervention.
AB - Background Sensitive general cardiometabolic risk assessment tools of modifiable risk factors would be helpful and practical in a range of primary prevention interventions or for preventive health maintenance. Purpose To develop and validate a cumulative general cardiometabolic risk score that focuses on non-self-reported modifiable risk factors such as glycosylated hemoglobin (HbA1c) and BMI so as to be sensitive to small changes across a span of major modifiable risk factors, which may not individually cross clinical cut-off points for risk categories. Methods We prospectively followed 2,359 cardiovascular disease (CVD)-free subjects from the Framingham offspring cohort over a 14-year follow-up. Baseline (fifth offspring examination cycle) included HbA1c and cholesterol measurements. Gender-specific Cox proportional hazards models were considered to evaluate the effects of non-self-reported modifiable risk factors (blood pressure, total cholesterol, high-density lipoprotein cholesterol, smoking, BMI, and HbA1c) on general CVD risk. We constructed 10-year general cardiometabolic risk score functions and evaluated its predictive performance in 2012-2013. Results HbA1c was significantly related to general CVD risk. The proposed cardiometabolic general CVD risk model showed good predictive performance as determined by cross-validated discrimination (male C-index=0.703, 95% CI=0.668, 0.734; female C-index=0.762, 95% CI=0.726, 0.801) and calibration (lack-of-fit chi-square=9.05 [p=0.338] and 12.54 [p=0.128] for men and women, respectively). Conclusions This study presents a risk factor algorithm that provides a convenient and informative way to quantify cardiometabolic risk on the basis of modifiable risk factors that can motivate an individual's commitment to prevention and intervention.
UR - http://www.scopus.com/inward/record.url?scp=84904644369&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84904644369&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2014.03.006
DO - 10.1016/j.amepre.2014.03.006
M3 - Article
C2 - 24951039
AN - SCOPUS:84904644369
SN - 0749-3797
VL - 47
SP - 131
EP - 140
JO - American Journal of Preventive Medicine
JF - American Journal of Preventive Medicine
IS - 2
ER -